Results 131 to 140 of about 191,868 (197)

Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells. [PDF]

Mol Ther Nucleic Acids
Hinata D, Kai Y, Fukuda R, Kamada Y, Kasahara Y, Sasaki K, Yoshida T, Obika S, Inoue T, Okiyoneda T.   +9 more
europepmc   +1 more source

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients. [PDF]

J Clin Med
Pócsi M, Fila L, Péterfia C, Halász A, Szanto TG, Mészáros B, Major J, Laki I, Szabó H, Panyi G, Balogh I, Amaral MD, Macek M, Nagy B.   +13 more
europepmc   +1 more source

Frequency Response Analysis of MEMS Comb-Drive Resonator Integrated With a Polymer Thin Film Layer

Electrica
Serdar Tez, Mehmet Kaya
doaj   +1 more source

Preoperative malignancy risk assessment in pancreatic cystic neoplasms using clinical and laboratory parameters. [PDF]

World J Gastrointest Surg
Martli HF, Acehan F, Şimşek A, Şahingöz E, Sürel AA, Er S, Tez M.   +6 more
europepmc   +1 more source

The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review. [PDF]

Diabetologia
Sharpe H, Lam GY.
europepmc   +1 more source

Kitap tanıtımı-tez tanıtımı-kongre ve sempozyum duyuruları

Ankara Üniversitesi Eğitim Bilimleri Fakültesi Özel Eğitim Dergisi, 2003
Editörden
doaj   +1 more source

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring. [PDF]

Molecules
D'Atri V, Corrado F, Versace F, Saldanha SA, Mercier T, Guidi M, Thoueille P, Blanchon S, Koutsokera A, Vogeser M, Marzolini C, Girardin F, Mitropoulou G, Balmpouzis Z, Rochat I, Sauty A, Decosterd LA, Choong E.   +17 more
europepmc   +1 more source

Eosinophilic infiltration in gallbladder pathologies: A clinical dilemma. [PDF]

Saudi Med J
Martlı HF, Aydın AH, Şahingöz E, Er S, Akgül Ö, Turhan N, Tez M.   +6 more
europepmc   +1 more source

ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis. [PDF]

Nucleic Acids Res
Ko W, Porter JJ, Spelier S, Sorensen EG, Bhatt P, Gabell JT, van der Windt I, Couch T, Coote K, Mense M, Beekman JM, Lueck JD.   +11 more
europepmc   +1 more source